Role of neuromodulation and optogenetic manipulation in pain treatment

Sufang Liu, Changsheng Li, Ying Xing, Yanqing Wang, Feng Tao

Research output: Contribution to journalArticle

Abstract

Neuromodulation, including invasive and non-invasive stimulation, has been used to treat intractable chronic pain. However, the mechanisms by which neuromodulation produces antinociceptive effect still remain uncertain. Optogenetic manipulation, a recently developed novel approach, has already proven its value to clinicians by providing new insights into mechanisms of current clinical neuromodulation methods as well as pathophysiology of nervous system diseases at the circuit level. Here, we discuss the principles of two neuromodulation methods (deep brain stimulation and motor cortex stimulation) and their applications in pain treatment. More important, we summarize the new information from recent studies regarding optogenetic manipulation in neuroscience research and its potential utility in pain study.

Original languageEnglish (US)
Pages (from-to)654-661
Number of pages8
JournalCurrent Neuropharmacology
Volume14
Issue number6
StatePublished - Aug 1 2016
Externally publishedYes

Fingerprint

Optogenetics
Pain
Intractable Pain
Deep Brain Stimulation
Motor Cortex
Neurosciences
Nervous System Diseases
Chronic Pain
Therapeutics
Research

Keywords

  • Brain stimulation
  • Neuromodulation
  • Optogenetic manipulation
  • Pain

ASJC Scopus subject areas

  • Clinical Neurology
  • Pharmacology (medical)
  • Pharmacology
  • Neurology
  • Psychiatry and Mental health

Cite this

Liu, S., Li, C., Xing, Y., Wang, Y., & Tao, F. (2016). Role of neuromodulation and optogenetic manipulation in pain treatment. Current Neuropharmacology, 14(6), 654-661.

Role of neuromodulation and optogenetic manipulation in pain treatment. / Liu, Sufang; Li, Changsheng; Xing, Ying; Wang, Yanqing; Tao, Feng.

In: Current Neuropharmacology, Vol. 14, No. 6, 01.08.2016, p. 654-661.

Research output: Contribution to journalArticle

Liu, S, Li, C, Xing, Y, Wang, Y & Tao, F 2016, 'Role of neuromodulation and optogenetic manipulation in pain treatment', Current Neuropharmacology, vol. 14, no. 6, pp. 654-661.
Liu S, Li C, Xing Y, Wang Y, Tao F. Role of neuromodulation and optogenetic manipulation in pain treatment. Current Neuropharmacology. 2016 Aug 1;14(6):654-661.
Liu, Sufang ; Li, Changsheng ; Xing, Ying ; Wang, Yanqing ; Tao, Feng. / Role of neuromodulation and optogenetic manipulation in pain treatment. In: Current Neuropharmacology. 2016 ; Vol. 14, No. 6. pp. 654-661.
@article{f6ea94f74b444422be3a77775e2283d6,
title = "Role of neuromodulation and optogenetic manipulation in pain treatment",
abstract = "Neuromodulation, including invasive and non-invasive stimulation, has been used to treat intractable chronic pain. However, the mechanisms by which neuromodulation produces antinociceptive effect still remain uncertain. Optogenetic manipulation, a recently developed novel approach, has already proven its value to clinicians by providing new insights into mechanisms of current clinical neuromodulation methods as well as pathophysiology of nervous system diseases at the circuit level. Here, we discuss the principles of two neuromodulation methods (deep brain stimulation and motor cortex stimulation) and their applications in pain treatment. More important, we summarize the new information from recent studies regarding optogenetic manipulation in neuroscience research and its potential utility in pain study.",
keywords = "Brain stimulation, Neuromodulation, Optogenetic manipulation, Pain",
author = "Sufang Liu and Changsheng Li and Ying Xing and Yanqing Wang and Feng Tao",
year = "2016",
month = "8",
day = "1",
language = "English (US)",
volume = "14",
pages = "654--661",
journal = "Current Neuropharmacology",
issn = "1570-159X",
publisher = "Bentham Science Publishers B.V.",
number = "6",

}

TY - JOUR

T1 - Role of neuromodulation and optogenetic manipulation in pain treatment

AU - Liu, Sufang

AU - Li, Changsheng

AU - Xing, Ying

AU - Wang, Yanqing

AU - Tao, Feng

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Neuromodulation, including invasive and non-invasive stimulation, has been used to treat intractable chronic pain. However, the mechanisms by which neuromodulation produces antinociceptive effect still remain uncertain. Optogenetic manipulation, a recently developed novel approach, has already proven its value to clinicians by providing new insights into mechanisms of current clinical neuromodulation methods as well as pathophysiology of nervous system diseases at the circuit level. Here, we discuss the principles of two neuromodulation methods (deep brain stimulation and motor cortex stimulation) and their applications in pain treatment. More important, we summarize the new information from recent studies regarding optogenetic manipulation in neuroscience research and its potential utility in pain study.

AB - Neuromodulation, including invasive and non-invasive stimulation, has been used to treat intractable chronic pain. However, the mechanisms by which neuromodulation produces antinociceptive effect still remain uncertain. Optogenetic manipulation, a recently developed novel approach, has already proven its value to clinicians by providing new insights into mechanisms of current clinical neuromodulation methods as well as pathophysiology of nervous system diseases at the circuit level. Here, we discuss the principles of two neuromodulation methods (deep brain stimulation and motor cortex stimulation) and their applications in pain treatment. More important, we summarize the new information from recent studies regarding optogenetic manipulation in neuroscience research and its potential utility in pain study.

KW - Brain stimulation

KW - Neuromodulation

KW - Optogenetic manipulation

KW - Pain

UR - http://www.scopus.com/inward/record.url?scp=84978285048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978285048&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84978285048

VL - 14

SP - 654

EP - 661

JO - Current Neuropharmacology

JF - Current Neuropharmacology

SN - 1570-159X

IS - 6

ER -